Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

ANGIODYNAMICS INC
Next earnings Jul 13, 2026 (after close) · consensus $-0.09 EPS, $82.0M rev
Last earnings -13.7% on 2026-04-02
Conservative balance sheet (liabilities/equity 0.53x); but revenue declined -3.8% YoY.
ANGIODYNAMICS INC shows $292M in FY2025 revenue (-3.8% YoY), a -11.6% net margin, and -18.6% ROE.
Sources: SEC EDGAR (CIK 0001275187, latest 10-Q filed 2026-04-02) · EODHD · as of 6/22/2026, 1:54:24 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $291M | $316M | $339M | $304M | $292M |
| Gross profit | $157M | $166M | $174M | $155M | $158M |
| Operating income | -$35.3M | -$28.5M | -$51.2M | -$192M | -$40.0M |
| Net income | -$31.5M | -$26.5M | -$52.4M | -$184M | -$34.0M |
| Diluted EPS | -$0.82 | -$0.68 | -$1.33 | -$4.59 | -$0.83 |
| Net margin | -10.8% | -8.4% | -15.5% | -60.7% | -11.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1483 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
| 2025-10-21 | Weiss Lawrence T SVP, Chief Legal Officer | Buy | 10.0K @ $11.81 | $118K |
| 2025-10-13 | Trowbridge Stephen A EVP and CFO | Buy | 890.00 @ $11.16 | $9.93K |
| 2025-10-09 | Clemmer James C President and CEO | Buy | 10.0K @ $11.15 | $112K |
| 2025-07-21 | Trowbridge Stephen A EVP and CFO | Tax | 667.00 @ $8.99 | $6.00K |
| 2025-07-21 | Nighan Warren JR SVP Quality and Regulatory | Tax | 277.00 @ $8.99 | $2.49K |
| 2025-07-21 | Campbell Chad Thomas SVP/GM, Vascular Access | Tax | 395.00 @ $8.99 | $3.55K |
| 2025-07-20 | Trowbridge Stephen A EVP and CFO | Tax | 717.00 @ $8.69 | $6.23K |
| 2025-07-20 | Piccinini Laura SVP International | Tax | 616.00 @ $8.69 | $5.35K |
| 2025-07-20 | Nighan Warren JR SVP Quality and Regulatory | Tax | 251.00 @ $8.69 | $2.18K |
| 2025-07-20 | Clemmer James C President and CEO | Tax | 2.98K @ $8.69 | $25.9K |
| 2025-07-20 | Clemmer James C President and CEO | Tax | 3.67K @ $8.99 | $33.0K |
| 2025-07-20 | Campbell Chad Thomas SVP/GM, Vascular Access | Tax | 359.00 @ $8.69 | $3.12K |